Cold Chain Smart Solutions Conference

Fleming Europe19 - 21 January 2011, Barcelona, Spain
The Cold Chain Smart Solutions Conference is the perfect place to get up to speed with the latest regulations, technology and processes that are necessary to operate a cost-effective and compliant temperature controlled supply chain.

Due to greater temperature ranges and novel biotech drugs coming onto market the number of cold chain shipments by air, road and sea continue increasing. Temperature controlled and pharmaceutical shipping are widely expected to lead the recovery in terms of growth rates. Therefore the most immediate investment priorities of pharmaceutical, shipper, wholesaler companies and CMOs should include cold chain capabilities.

By attending you will have the chance to listen to conference presentations, panel discussions, specialist discussion forums, tailor-made streams about the burning topics of the industry - such as the most updated regulatory roadmap, quality systems and agreements, RF-enabled product visibility, electronic temperature monitoring, satellite tracking, "Last mile" issues, new market focus on Asia, shipping by ocean, cold chain packaging & shipping smart solutions: PCM, going green, active ULDs, battery-assisted passive RFID, etc.

In the frame of a highly interactive Post-Conference Workshop you will gain an insight into the newest real-life strategies how to mitigate the risks and optimize the cold chain costs efficaciously.

Furthermore, you will have excellent opportunities to network with temperature controlled supply chain stakeholders from:

  • Pharmaceutical, Biotech and Medical Device Manufacturers
  • Transportation Providers
  • Government Healthcare Agencies and Shippers
  • Freight forwarders
  • Packaging Partners
  • Wholesalers

As a comprehensive and one-of-its kind event, the Cold Chain Smart Solutions Conference will address the most urgent challenges of the global marketplace for the storage and distribution of temperature sensitive pharmaceuticals, biopharmaceuticals, vaccines, etc.

For further information and brochure request, please visit:
http://www.flemingeurope.com/life-science-conferences/europe/cold-chain-smart-solutions

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

SMi Group announces the 9th Annual RNA Therapeutic…

21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]